RxDoctor Payments Data

Brent Bernstein

Foot & Ankle Surgery · Bethlehem, PANPI 1003878927

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (34.5%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. KCI USA, Inc. accounts for 72.3% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2019 at $28,607 and has fallen 77.9% since, to $6,310 in 2025. Among foot & ankle surgery clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$39,345in general payments, 2019–2025

Across 89 payments — averaging $442.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • KCI USA, Inc.$28K
  • Paragon 28, Inc.$5K
  • Arthrex$3K
  • Aroa Biosurgery Incorporated$778
  • Stryker$649
  • Integra Lifesciences Corporation$607
  • plus $1K from 14 others
$4,808in research payments, 2019–2025

Across 5 payments — averaging $961.61 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Zimmer Biomet$5K

What the payments were for

  • Consulting fees$13,57034%
  • Speaking & faculty fees$11,25029%
  • Travel & lodging$8,84822%
  • Food & beverage$4,47711%
  • Education$1,2003%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
KCI USA, Inc.27$28,437
Paragon 28, Inc.10$4,674
Arthrex8$2,773
Aroa Biosurgery Incorporated3$778
Stryker6$649
Integra Lifesciences Corporation13$607
Novus Surgical Consultants3$375
Novus Surgical Solutions LLC3$206
Smith+Nephew2$170
Paratek Pharmaceuticals, Inc.3$140
Inari Medical, Inc.1$95
DJO, LLC1$89
Coastal Medical Technologies LLC1$83
Solventum Corporation1$79
Organogenesis Inc.2$74
Acumed LLC1$55
Musculoskeletal Transplant Foundation Inc.1$20
Biocomposites Inc1$16
Merck1$15
Bioventus LLC1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$39,345 in reported general payments places this provider in the 95th percentile of 575 foot & ankle surgery providers in Pennsylvania.

See all foot & ankle surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$77,585
Medicare patients
187
Services billed
681

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lidocaine15$1,457
Mupirocin57$392
Cephalexin19$169
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen15$92

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Bethlehem

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →